Anna Wolska-Washer

8PUBLICATIONS
11CO-AUTHORS
Microbial geneticsMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 07, 2026
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.

|Aug 27, 2026
BTK Inhibitors for the Treatment of Mantle Cell Lymphoma-Current Status and Perspectives.

|Oct 04, 2024
The role of antibody therapies in treating relapsed chronic lymphocytic leukemia: a review.

Magdalena Witkowska, Agata Majchrzak, Paweł Robak

|Oct 03, 2024
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance.

Tadeusz Robak, Magdalena Witkowska, Anna Wolska-Washer

|Mar 22, 2024
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Anna Wolska-Washer, Paweł Robak, Magdalena Witkowska

|Sep 15, 2023
Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia.

Magdalena Witkowska, Agata Majchrzak, Paweł Robak

Pageof 2

Frequent Collaborators

7 joint publications

Tadeusz Robak

5 joint publications

Paweł Robak

1 joint publications

Magdalena Witkowska

1 joint publications

Monika Szelest